Affinage

Showing ECPASKIAA0368 is a alias.

ECPAS

Proteasome adapter and scaffold protein ECM29 · UniProt Q5VYK3

Length
1845 aa
Mass
204.3 kDa
Annotated
2026-06-09
15 papers in source corpus 15 papers cited in narrative 15 extracted findings
Cross-family judge vs UniProt: Affinage preferred faithfulness: 7/7 claims corpus-supported (100%)

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

ECPAS (Ecm29) is a large HEAT-repeat scaffold protein that associates with the 26S proteasome as a quality-control and adaptor factor, coupling proteolysis to proteasome integrity surveillance, stress responses, and subcellular targeting (PMID:15496406, PMID:20682791). It functions as a proteasome chaperone that monitors regulatory particle–core particle (RP-CP) assembly, recognizing stalled or aberrant assemblies and remodeling them into mature enzymes (PMID:20620957). ECPAS preferentially associates with mutant and nucleotide-depleted proteasomes through dual binding sites—the phosphorylated C-terminal tail of the α7 core subunit and the Rpt5 ATPase of the 19S regulatory particle—a requirement for two sites on different subcomplexes that explains its specificity for holoenzymes and aberrant species (PMID:21878651, PMID:23995839, PMID:27302526). Engagement of aberrant proteasomes inhibits ATPase activity and induces closure of the 20S substrate-entry gate, blocking degradation of ubiquitin-dependent and -independent substrates (PMID:23995839). Under stress—oxidative stress or glucose starvation—ECPAS is the principal driver of 26S disassembly into 20S and 19S subcomplexes, intruding on the 20S–19S interface, a function conserved from yeast to human (PMID:26802743, PMID:28821611, PMID:37384533). Beyond holoenzyme regulation, ECPAS acts as a subcellular adaptor: its C-terminal half binds molecular motors (myosins, kinesins) and its N-terminal region binds endocytic proteins, tethering proteasomes to flotillin-positive endosomes (PMID:20682791), to the axon initial segment via ankyrin G where it controls NKCC1 levels and the GABAergic developmental switch (PMID:31910261), and to the centrosome of B cells to coordinate proteasome distribution with actin dynamics at the immune synapse (PMID:34055780). ECPAS additionally cooperates with PA200 during spermatogenesis, targeting LPIN1 and supporting mitochondrial sheath organization (PMID:37189334), and governs CNS immune tolerance through fidelity of neuroglial self-antigen generation (PMID:39786996).

Mechanistic history

Synthesis pass · year-by-year structured walk · 15 steps
  1. 2004 Medium

    Established that mammalian Ecm29 is a dedicated 26S proteasome partner with a non-uniform subcellular distribution, raising the possibility that it couples proteolysis to specific compartments.

    Evidence Glycerol-gradient fractionation and confocal immunofluorescence in HeLa and toxin-resistant CHO cells

    PMID:15496406

    Open questions at the time
    • Functional role at the centrosome/secretory compartments not defined
    • No molecular mechanism for targeting
    • Correlative link to ERAD only
  2. 2010 High

    Defined Ecm29 as a scaffold/chaperone for proteasome biogenesis, answering whether it acts on assembled enzymes versus assembly intermediates.

    Evidence Yeast genetics and proteasome reconstitution assays of stalled RP-CP species

    PMID:20620957

    Open questions at the time
    • Structural basis of intermediate recognition not resolved
    • Trigger for Ecm29 degradation upon maturation not detailed
  3. 2010 High

    Mapped Ecm29 as a bipartite adaptor linking proteasomes to motors and endocytic machinery, explaining how proteasomes reach specific endosomes.

    Evidence Two-hybrid screens, mass spectrometry, domain mapping and confocal microscopy in human cells

    PMID:20682791

    Open questions at the time
    • Cargo/proteolytic consequence at flotillin endosomes unknown
    • Direct vs indirect motor binding not distinguished structurally
  4. 2011 Medium

    Showed Ecm29's own stability and proteasome engagement are regulated by the Not4 E3 ligase, situating it within a regulatory circuit.

    Evidence Yeast deletion strains, co-immunoprecipitation, and ubiquitination assays

    PMID:21321079

    Open questions at the time
    • Direct Not4 ubiquitination of Ecm29 not demonstrated
    • Mechanism by which Not4 promotes Ecm29-proteasome binding unclear
  5. 2011 Medium

    Established Ecm29 as a negative regulator that selectively recognizes and inhibits defective proteasomes, defining a surveillance function.

    Evidence Genetic epistasis (rpt5-Δ3, nas2Δ, hsm3Δ) with peptidase activity assays in yeast

    PMID:21878651

    Open questions at the time
    • Biochemical mode of inhibition not yet defined here
    • Whether inhibition is reversible unknown
  6. 2013 High

    Provided the biochemical mechanism of inhibition—ATPase suppression and 20S gate closure—and localized binding to Rpt5, converting the genetic phenotype into a molecular model.

    Evidence In vitro peptidase/ATPase assays, in vivo substrate degradation, cross-linking MS, and EM gate analysis

    PMID:23995839

    Open questions at the time
    • Atomic structure of Ecm29-proteasome complex absent
    • How aberrant-proteasome features are sensed not fully resolved
  7. 2013 Medium

    Connected Ecm29-proteasomes to innate immune signaling and autophagy, broadening its role beyond proteasome integrity.

    Evidence siRNA depletion in HEK-293/HeLa with immunoblot and immunofluorescence readouts of TLR3 pathway

    PMID:24084648

    Open questions at the time
    • Direct proteasomal substrate in TLR3 pathway not identified
    • Whether effect is via proteasome tethering or activity control unclear
  8. 2016 Medium

    Revealed phosphorylation-dependent dual-site binding (α7-tail plus Rpt5), explaining how Ecm29 achieves specificity for holoenzymes and aberrant proteasomes.

    Evidence Yeast α7 phospho-tail mutants with co-IP and proteasome purification

    PMID:27302526

    Open questions at the time
    • Kinase responsible for α7 phosphorylation not identified
    • Stoichiometry of the two-site engagement unresolved
  9. 2016 Medium

    Demonstrated in mice that Ecm29 is required for stress-induced 26S dissociation, linking it to oxidative-stress proteostasis in vivo.

    Evidence KIAA0368-deficient mice with native gel analysis and oxidative stress challenge

    PMID:26802743

    Open questions at the time
    • Signal transducing oxidative state to Ecm29 unknown
    • Physiological consequence of failed dissociation only partly characterized
  10. 2017 High

    Identified Ecm29 as the main driver of stress-triggered 26S disassembly and proposed a structural mechanism (intrusion at the 20S-19S interface), conserved across species.

    Evidence Cross-linking-assisted affinity purification with SILAC MS and integrative structural modeling in human cells

    PMID:28821611

    Open questions at the time
    • High-resolution structure of the disassembly intermediate lacking
    • Reversibility and reassembly kinetics not measured
  11. 2020 High

    Showed Ecm29 tethers proteasomes to the axon initial segment via ankyrin G, controlling NKCC1 levels and neuronal GABAergic maturation—a spatially defined physiological role.

    Evidence Ecm29 KO mice, domain-deletion constructs, imaging, electrophysiology, and rescue experiments

    PMID:31910261

    Open questions at the time
    • Whether AIS proteasomes degrade NKCC1 directly not proven
    • Generality across neuron types untested
  12. 2021 Medium

    Established that Ecm29-controlled asymmetric proteasome distribution between centrosome and cortex coordinates actin dynamics and antigen presentation at the B-cell immune synapse.

    Evidence siRNA silencing in B cells with confocal imaging, actin flow, and antigen extraction/presentation assays

    PMID:34055780

    Open questions at the time
    • Molecular link between proteasome position and F-actin regulation unclear
    • Knockdown rather than knockout; off-target not excluded
  13. 2023 High

    Extended ECPAS-driven 26S disassembly to glucose starvation and showed it sustains 20S-mediated degradation and survival, with relevance to nutrient-deprived tumors.

    Evidence ECPAS KO cells, subcomplex affinity purification, quantitative MS, in silico modeling, and xenograft model

    PMID:37384533

    Open questions at the time
    • Sensor coupling glucose status to ECPAS conformation unknown
    • In vivo tumor dependence on ECPAS not directly tested by KO
  14. 2023 Medium

    Defined a cooperative ECPAS–PA200 axis in spermatogenesis with LPIN1 as a shared target, linking ECPAS to germ-cell proteostasis and structure.

    Evidence PA200/ECPAS double-knockout mice, MS substrate identification, immunostaining, and ultrastructural analysis

    PMID:37189334

    Open questions at the time
    • Whether LPIN1 is a direct degradation substrate not shown
    • Single-KO contributions versus dKO not separated
  15. 2025 Medium

    Showed Ecm29-controlled proteasome activity in neuroglia governs CNS immune tolerance through fidelity of self-antigen generation.

    Evidence Inducible conditional Ecm29 KO mice, EAE model, immunopeptidome MS, AAV antigen rescue, and flow cytometry

    PMID:39786996

    Open questions at the time
    • Molecular basis of altered antigen processing not mechanistically resolved
    • Whether effect reflects 26S dissociation or tethering function unclear

Open questions

Synthesis pass · forward-looking unresolved questions
  • A high-resolution structure of ECPAS bound to the proteasome and the upstream signals (kinases, sensors) that switch ECPAS between chaperone, inhibitor, disassembly, and tethering modes remain undefined.
  • No atomic-resolution ECPAS-proteasome structure
  • Signal-to-conformation coupling for stress-induced disassembly unknown
  • Direct degradation substrates across tissues largely uncatalogued

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 4 GO:0060090 molecular adaptor activity 3 GO:0140096 catalytic activity, acting on a protein 2 GO:0008092 cytoskeletal protein binding 1
Localization
GO:0005768 endosome 2 GO:0005815 microtubule organizing center 2 GO:0005856 cytoskeleton 2 GO:0005783 endoplasmic reticulum 1
Pathway
R-HSA-392499 Metabolism of proteins 4 R-HSA-168256 Immune System 3 R-HSA-8953897 Cellular responses to stimuli 3
Complex memberships
26S proteasome

Evidence

Reading pass · 15 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2004 Mammalian Ecm29 is present exclusively on 26S proteasomes in HeLa cells and localizes to the centrosome and a subset of secretory compartments including endosomes, the ER, and the ERGIC, as determined by confocal immunofluorescence microscopy and glycerol-gradient fractionation. Ecm29 is up-regulated 2–3-fold in toxin-resistant CHO cells with increased ER-associated degradation, suggesting it couples 26S proteasomes to secretory compartments engaged in quality control. Antibody generation, glycerol-gradient fractionation, confocal immunofluorescence microscopy, CHO mutant cell line analysis The Journal of biological chemistry Medium 15496406
2010 Ecm29 controls the integrity of RP-CP (regulatory particle–core particle) assemblies in yeast, recognizing RP-CP species in which CP maturation is stalled due to the lack of distinct beta subunits. Reconstitution assays demonstrated that Ecm29 functions as a scaffold protein during remodeling of incompletely matured RP-CP assemblies into regular enzymes, and is degraded upon completion of CP maturation. Yeast genetics, proteasome reconstitution assays, biochemical fractionation Molecular cell High 20620957
2010 The C-terminal half of human Ecm29 binds myosins and kinesins (molecular motors), while the N-terminal region binds endocytic proteins Vps11, Rab11-FIP4, and rabaptin. A central fragment of Ecm29 is sufficient for 26S proteasome binding. Ecm29-26S proteasomes are present on flotillin-positive endosomes but absent from caveolin- and clathrin-decorated endosomes. Expression of the central fragment reduces proteasome association with flotillin-positive endosomes. Genome-wide two-hybrid screens, mass spectrometry, confocal microscopy, glycerol-gradient fractionation, domain mapping with truncation constructs The Journal of biological chemistry High 20682791
2011 Not4 E3 ligase associates with the regulatory particle (RP) of the proteasome holoenzyme and interacts with Ecm29. In the absence of Not4, Ecm29 interacts less well with the proteasome, becomes ubiquitinated and degraded. This indicates that appropriate Ecm29-proteasome interaction requires Not4, establishing Ecm29 as a proteasome chaperone whose stability depends on Not4-mediated regulation. Yeast genetics (deletion strains), co-immunoprecipitation, ubiquitination assay, proteasome purification and activity assays Molecular and cellular biology Medium 21321079
2011 Ecm29 is enriched on proteasomes purified from Saccharomyces cerevisiae rpt5-Δ3 strains (faulty proteasomes), and these Ecm29-containing proteasomes have reduced suc-LLVY-AMC hydrolytic activity. Deletion of ECM29 rescues phenotypes of rpt5-Δ3 and nas2Δ in an hsm3Δ background, establishing Ecm29 as a negative regulator/inhibitor that recognizes and inhibits aberrant proteasomes. Yeast genetics (deletion strains, epistasis analysis), proteasome purification, peptidase activity assay The Journal of biological chemistry Medium 21878651
2013 Ecm29 inhibits proteasomal ATPase activity and induces a closed conformation of the substrate entry channel of the 20S core particle. Besides inhibiting peptide substrate cleavage in vitro, Ecm29 inhibits degradation of ubiquitin-dependent and -independent substrates in vivo. Chemical cross-linking identified that Ecm29 binds to or in close proximity to proteasomal ATPase subunit Rpt5. Ecm29 preferentially associates with mutant and nucleotide-depleted proteasomes. In vitro peptidase and ATPase activity assays, in vivo ubiquitin-dependent substrate degradation assays, chemical cross-linking mass spectrometry, electron microscopy (gate conformation) The Journal of biological chemistry High 23995839
2013 Depletion of Ecm29 increases abundance of TLR3 and increases levels of LC3β and p62 (autophagy mediators). Loss of Ecm29 enhances TLR3 signaling, characterized by increased TRAF3 levels, increased phosphorylation of effector kinases, increased nuclear localization of IRF3, and accumulation of signaling molecules at juxtanuclear recycling endosomes. This establishes that Ecm29-associated proteasomes play a role in mediating autophagy and attenuation of TLR3-dependent signaling. siRNA depletion of Ecm29 in HEK-293 and HeLa cells, immunoblotting, immunofluorescence microscopy Science signaling Medium 24084648
2016 Yeast Ecm29 requires the phosphorylated C-terminal tail of the proteasome α7 subunit for its association with the proteasome. This represents the first example of phosphorylation-dependent binding of a proteasome regulatory factor. The ability of Ecm29 to bind mutant proteasomes requires both the α7-tail phosphorylation-dependent binding site and a previously identified Rpt5 binding site; the need for two binding sites on different subcomplexes explains the specificity of Ecm29 for proteasome holoenzymes. Yeast genetics (α7 tail phosphorylation mutants), co-immunoprecipitation/pulldown, proteasome purification Scientific reports Medium 27302526
2016 KIAA0368-deficient (Ecm29 knockout) mice show normal peptidase activity and proteasome formation under basal conditions, but fail to dissociate 26S proteasomes under oxidative stress conditions where wild-type cells dissociate 26S proteasomes. This correlates with reduced degradation of damaged proteins and increased resistance to oxidative stress in KIAA0368-deficient cells, establishing Ecm29 as required for 26S proteasome dissociation under stress. KIAA0368-deficient mouse generation, native gel proteasome analysis, peptidase activity assays, oxidative stress challenge Journal of biochemistry Medium 26802743
2017 Human Ecm29 is the main proteasome-interacting protein responsible for stress-triggered (H2O2) disassembly of the 26S proteasome. Cross-linking mass spectrometry mapped Ecm29 interactions within itself and with proteasome subunits; integrative structural modeling proposed that Ecm29 intrudes on the interaction between the 20S core particle and the 19S regulatory particle, disrupting proteasome structure in response to oxidative stress. Stress-induced 26S disassembly is conserved from yeast to human. XAP (in vivo cross-linking-assisted affinity purification) with SILAC quantitative MS, disuccinimidyl sulfoxide cross-linking MS, integrative structural modeling The Journal of biological chemistry High 28821611
2020 Ecm29 mediates proteasome distribution to the axon initial segment (AIS) through interaction with the AIS scaffold protein ankyrin G; both the Ecm29 N-terminal domain and an intact AIS structure are required for transport and tethering of proteasomes in the AIS region. Ecm29 knockout in neurons increases NKCC1 protein density in the AIS, delays the GABAergic response switch, and increases action potential firing frequency at early postnatal ages. Ecm29 KO neurons show accelerated AIS developmental positioning, rescued by ectopic Ecm29 expression or NKCC1 inhibition. Ecm29 knockout mouse, confocal and live imaging, domain deletion constructs, electrophysiology, chemical convulsive seizure assay, rescue experiments The Journal of cell biology High 31910261
2021 Ecm29 regulates proteasome distribution between the centrosome and cell cortex in B cells. Silencing Ecm29 shifts the proteasome from the centrosome to the cell cortex and immunological synapse (IS), resulting in increased F-actin at the centrosome, impaired centrosome and lysosome repositioning to the IS, defective antigen extraction and presentation, decreased actin retrograde flow in lamellipodia, and enhanced spreading. This establishes that Ecm29-controlled asymmetric proteasome distribution coordinates actin dynamics at the centrosome and IS. siRNA silencing of Ecm29 in B cells, confocal microscopy, actin dynamics measurement, antigen extraction and presentation assays Frontiers in cell and developmental biology Medium 34055780
2023 ECPAS mediates 26S proteasome disassembly into 20S and 19S subcomplexes in response to glucose starvation. Loss of ECPAS abrogates 26S dissociation and reduces degradation of 20S proteasome substrates including puromycylated polypeptides. In silico modeling suggests ECPAS conformational changes initiate the disassembly process. ECPAS is also essential for ER stress response and cell survival during glucose starvation. Elevated 20S proteasome levels are found in glucose-deprived tumors in vivo in a xenograft model. ECPAS KO cells, subcomplex affinity purification, quantitative mass spectrometry, in silico structural modeling, xenograft mouse model, puromycylated polypeptide degradation assay Cell reports High 37384533
2023 PA200 and ECPAS work cooperatively during spermatogenesis; double knockout (dKO) mice are infertile with considerably reduced proteasome activity in testes and epididymides. In epididymal sperm, ECPAS localizes to the acrosome. Mass spectrometric analysis identified LPIN1 as a target protein for both PA200 and ECPAS (confirmed by immunoblotting and immunostaining). dKO sperm display disorganization of the mitochondrial sheath. Double-knockout mouse generation, mass spectrometry, immunoblotting, immunostaining, ultrastructural analysis, proteasome activity assay Biomolecules Medium 37189334
2025 Loss of Ecm29 in oligodendroglia or microglia (inducible conditional KO) increases susceptibility to experimental autoimmune encephalomyelitis (EAE) and reduces regulatory T cell populations in the spinal cord. Immunopeptidome profiling identified self-antigens (including NDUFA1p) whose generation fidelity depends on Ecm29/proteasome function, and intraspinal AAV-mediated expression of NDUFA1p ameliorates EAE and expands NDUFA1p-recognizing CD103+CD8+CD122+ Treg cells, establishing that Ecm29-controlled proteasome activity governs CNS immune tolerance through neuroglial antigen generation. Inducible conditional Ecm29 KO mice, EAE model, immunopeptidome profiling (MS), AAV-mediated antigen expression, flow cytometry Cell reports Medium 39786996

Source papers

Stage 0 corpus · 15 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2017 The proteasome-interacting Ecm29 protein disassembles the 26S proteasome in response to oxidative stress. The Journal of biological chemistry 83 28821611
2004 Characterization of mammalian Ecm29, a 26 S proteasome-associated protein that localizes to the nucleus and membrane vesicles. The Journal of biological chemistry 70 15496406
2011 Not4 E3 ligase contributes to proteasome assembly and functional integrity in part through Ecm29. Molecular and cellular biology 68 21321079
2010 A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components. The Journal of biological chemistry 66 20682791
2010 Ecm29 fulfils quality control functions in proteasome assembly. Molecular cell 62 20620957
2011 Loss of Rpt5 protein interactions with the core particle and Nas2 protein causes the formation of faulty proteasomes that are inhibited by Ecm29 protein. The Journal of biological chemistry 53 21878651
2013 The proteasome-associated protein Ecm29 inhibits proteasomal ATPase activity and in vivo protein degradation by the proteasome. The Journal of biological chemistry 43 23995839
2016 Phosphorylation of the C-terminal tail of proteasome subunit α7 is required for binding of the proteasome quality control factor Ecm29. Scientific reports 23 27302526
2016 KIAA0368-deficiency affects disassembly of 26S proteasome under oxidative stress condition. Journal of biochemistry 21 26802743
2020 Ecm29-mediated proteasomal distribution modulates excitatory GABA responses in the developing brain. The Journal of cell biology 14 31910261
2023 ECPAS/Ecm29-mediated 26S proteasome disassembly is an adaptive response to glucose starvation. Cell reports 13 37384533
2013 Depletion of the 26S proteasome adaptor Ecm29 increases Toll-like receptor 3 signaling. Science signaling 12 24084648
2023 Proteasome-Associated Proteins, PA200 and ECPAS, Are Essential for Murine Spermatogenesis. Biomolecules 11 37189334
2021 Ecm29-Dependent Proteasome Localization Regulates Cytoskeleton Remodeling at the Immune Synapse. Frontiers in cell and developmental biology 11 34055780
2025 ECM29/proteasome-mediated self-antigen generation by CNS-resident neuroglia promotes regulatory T cell activation. Cell reports 1 39786996

Missed literature

Know a paper Affinage missed for ECPAS? Flag it for the maintainers and the community.

No submissions yet.